These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 19763505

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H.
    Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A, Fraizer GC, Piantanelli L, Saunders GF.
    Anticancer Res; 2001 Oct 15; 21(1A):1-10. PubMed ID: 11299720
    [Abstract] [Full Text] [Related]

  • 4. Specific block of androgen receptor activity by antisense oligonucleotides.
    Hamy F, Brondani V, Spoerri R, Rigo S, Stamm C, Klimkait T.
    Prostate Cancer Prostatic Dis; 2003 Oct 15; 6(1):27-33. PubMed ID: 12664061
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ, Robson CN, Neal DE, Leung HY.
    Oncogene; 2002 Aug 01; 21(33):5069-80. PubMed ID: 12140757
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.
    Wang LG, Johnson EM, Kinoshita Y, Babb JS, Buckley MT, Liebes LF, Melamed J, Liu XM, Kurek R, Ossowski L, Ferrari AC.
    Cancer Res; 2008 Apr 15; 68(8):2678-88. PubMed ID: 18413735
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. EZC-prostate models offer high sensitivity and specificity for noninvasive imaging of prostate cancer progression and androgen receptor action.
    Seethammagari MR, Xie X, Greenberg NM, Spencer DM.
    Cancer Res; 2006 Jun 15; 66(12):6199-209. PubMed ID: 16778194
    [Abstract] [Full Text] [Related]

  • 11. Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector.
    Wang D, Wang Z, Tian J, He X, Chowdhury WH, Zhang X, Li S, Rodriguez R.
    Urol Oncol; 2010 Jun 15; 28(2):164-9. PubMed ID: 18440837
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line.
    Wang LG, Ossowski L, Ferrari AC.
    Oncogene; 2004 Jul 01; 23(30):5175-84. PubMed ID: 15156193
    [Abstract] [Full Text] [Related]

  • 14. c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer.
    Cai C, Hsieh CL, Shemshedini L.
    Mol Cancer Res; 2007 Jul 01; 5(7):725-35. PubMed ID: 17634427
    [Abstract] [Full Text] [Related]

  • 15. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z, Stober J, Gast A, Peterziel H, Hobisch A, Radmayr C, Hittmair A, Bartsch G, Cato AC, Klocker H.
    Cancer Detect Prev; 1996 Jul 01; 20(1):68-75. PubMed ID: 8907206
    [Abstract] [Full Text] [Related]

  • 16. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
    Jia L, Kim J, Shen H, Clark PE, Tilley WD, Coetzee GA.
    Mol Cancer Res; 2003 Mar 01; 1(5):385-92. PubMed ID: 12651911
    [Abstract] [Full Text] [Related]

  • 17. A cell-specific and selective effect on transactivation by the androgen receptor.
    Gordon DA, Chamberlain NL, Flomerfelt FA, Miesfeld RL.
    Exp Cell Res; 1995 Apr 01; 217(2):368-77. PubMed ID: 7698238
    [Abstract] [Full Text] [Related]

  • 18. Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter.
    Mizokami A, Yeh SY, Chang C.
    Mol Endocrinol; 1994 Jan 01; 8(1):77-88. PubMed ID: 8152432
    [Abstract] [Full Text] [Related]

  • 19. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP.
    Koochekpour S, Lee TJ, Wang R, Sun Y, Delorme N, Hiraiwa M, Grabowski GA, Culig Z, Minokadeh A.
    J Cell Biochem; 2007 Jun 01; 101(3):631-41. PubMed ID: 17171640
    [Abstract] [Full Text] [Related]

  • 20. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
    Yuan H, Gong A, Young CY.
    Carcinogenesis; 2005 Apr 01; 26(4):793-801. PubMed ID: 15661808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.